Lombard Odier Asset Management (Switzerland) Sa Twist Bioscience Corp Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$14.6 - $30.9 $930,910 - $1.97 Million	63,761 Added 51.0%	188,781 $2.85 Million
Q4 2022 Feb 14, 2023	SELL	$21.92 - $39.37 $575,115 - $1.03 Million	-26,237 Reduced 17.35%	125,020 $2.98 Million
Q3 2022 Nov 14, 2022	SELL	$33.44 - $56.56 $369,144 - $624,365	-11,039 Reduced 6.8%	151,257 $5.33 Million
Q2 2022 Aug 15, 2022	SELL	$26.2 - $54.0 $1.37 Million - $2.83 Million	-52,405 Reduced 24.41%	162,296 $5.67 Million
Q1 2022 May 16, 2022	BUY	$38.58 - $83.27 $561,068 - $1.21 Million	14,543 Added 7.27%	214,701 $10.6 Million
Q4 2021 Feb 14, 2022	SELL	$75.47 - $135.88 $1.26 Million - $2.27 Million	-16,726 Reduced 7.71%	200,158 $15.5 Million
Q3 2021 Nov 12, 2021	BUY	$95.64 - $131.48 $1.93 Million - $2.66 Million	20,208 Added 10.27%	216,884 $23.2 Million
Q2 2021 Aug 13, 2021	BUY	$88.13 - $142.06 $7.87 Million - $12.7 Million	89,273 Added 83.12%	196,676 $26.2 Million
Q1 2021 May 17, 2021	BUY	$105.48 - $207.97 $11.3 Million - $22.3 Million	107,403 New	107,403 $13.3 Million

Others Institutions Holding TWST

# of Institutions

256

Shares Held

66.8M

Call Options Held

127K

Put Options Held

45.4K

Artisan Partners Limited Partnership Milwaukee, WI

6.02M
Shares

$247 Million
0.43% of portfolio
Vanguard Group Inc Valley Forge, PA

5.62M
Shares

$231 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.42M
Shares

$223 Million
0.01% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

5.36M
Shares

$220 Million
2.3% of portfolio
Invesco Ltd. Atlanta, GA

3.64M
Shares

$150 Million
0.03% of portfolio

View Full List

About Twist Bioscience Corp

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.32B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

More about TWST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account